A

Allena Pharmaceuticals, Inc.

18 employees

Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Specific Nonabsorbed Oral Enzyme Therapeutics and Oral Biologics
Therapeutics
Pharmaceutical

Date founded

2011

Funding rounds raised

Total raised

$53M

from 14 investors over 14 rounds

A

Allena Pharmaceuticals, Inc. raised $25M on September 30, 2020

Investors: Pontifax Venture Capital

A

Allena Pharmaceuticals, Inc. raised undisclosed on November 2, 2017

Investors: Bessemer Venture Partners

A

Allena Pharmaceuticals, Inc. raised $53M on December 9, 2015

Investors: Inbio Ventures, Wellington Management, Frazier Healthcare Partners and -

A

Allena Pharmaceuticals, Inc. raised $25M on December 4, 2014

Investors: Inbio Ventures, HBM Partners AG, Third Rock Ventures, Bessemer Venture Partners and Frazier Healthcare Partners

A

Allena Pharmaceuticals, Inc. raised $15M on November 16, 2011

Investors: Bessemer Venture Partners, Third Rock Ventures and Frazier Healthcare Partners

FAQ